The pros and cons of early vs late initiation of direct OAC after acute ischemic stroke in the setting of AF for secondary prevention, was the topic of a lively debate at the EAN Congress.

The report captured data from more than 2000 practicing PAs working in over 29 specialties who filled out surveys in 2023. A ...

Early in-hospital administration of long-acting injectable (LAI) antipsychotics following a first admission for schizophrenia ...

The timing, as well as the amount, of daily physical activity was linked to better glucose control in sedentary adults with ...

Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high ...

Since President Emmanuel Macron's dissolution of the French government and announcement of new legislative elections, many ...

ORLANDO, Florida — With glucagon peptide-1 receptor agonist (GLP-1 RA) drugs known to have a rapid rebound of weight gain ...

This decision is backed by results of the FLAURA2 trial, highlighting the efficacy of Tagrisso plus chemotherapy in extending progression-free survival over Tagrisso alone.

Despite secondary prevention with OAC, the risk for recurrent stroke and mortality is high in patients with AF. However, OAC discontinuation is tied to a doubling of recurrent stroke.

Interim results of the INSPIRE trial showed improved limb function, mobility, pain, and fatigue in patients with SORD ...

Blocking interleukin 4 and interleukin 1 inflammatory pathways, dupilumab has shown efficacy in other atopic diseases such as ...

FDA-approved efgartigimod represents the first novel, precision mechanism of action in more than 30 years for CIDP.